Requirement for GD3 ganglioside in CD95-and ceramide-induced apoptosis R De Maria, L Lenti, F Malisan, F d'Agostino, B Tomassini, A Zeuner, ... Science 277 (5332), 1652-1655, 1997 | 535 | 1997 |
Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation YJ Liu, F Malisan, O de Bouteiller, C Guret, S Lebecque, J Banchereau, ... Immunity 4 (3), 241-250, 1996 | 425 | 1996 |
Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. F Malisan, F Bričre, JM Bridon, N Harindranath, FC Mills, EE Max, ... The Journal of experimental medicine 183 (3), 937-947, 1996 | 259 | 1996 |
GD3 ganglioside directly targets mitochondria in a bcl‐2‐controlled fashion MR Rippo, F Malisan, L Rayagnan, B Tomassini, I Condo, P Costantini, ... The FASEB Journal 14 (13), 2047-2054, 2000 | 221 | 2000 |
Differential regulation of apoptotic cell death in senescent human cells B Hampel, F Malisan, H Niederegger, R Testi, P Jansen-Dürr Experimental gerontology 39 (11-12), 1713-1721, 2004 | 161 | 2004 |
GD3 ganglioside and apoptosis F Malisan, R Testi Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2002 | 161 | 2002 |
In vivo maturation of human frataxin I Condo, N Ventura, F Malisan, A Rufini, B Tomassini, R Testi Human molecular genetics 16 (13), 1534-1540, 2007 | 140 | 2007 |
Acetylation suppresses the proapoptotic activity of GD3 ganglioside F Malisan, L Franchi, B Tomassini, N Ventura, I Condō, MR Rippo, ... The Journal of experimental medicine 196 (12), 1535-1541, 2002 | 124 | 2002 |
A pool of extramitochondrial frataxin that promotes cell survival I Condò, N Ventura, F Malisan, B Tomassini, R Testi Journal of Biological Chemistry 281 (24), 16750-16756, 2006 | 114 | 2006 |
Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans A Schiavi, A Torgovnick, A Kell, E Megalou, N Castelein, I Guccini, ... Experimental gerontology 48 (2), 191-201, 2013 | 77 | 2013 |
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin I Condo, F Malisan, I Guccini, D Serio, A Rufini, R Testi Human molecular genetics 19 (7), 1221-1229, 2010 | 77 | 2010 |
Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model B Tomassini, G Arcuri, S Fortuni, C Sandi, V Ezzatizadeh, C Casali, ... Human molecular genetics 21 (13), 2855-2861, 2012 | 75 | 2012 |
9‐O‐acetyl GD3 protects tumor cells from apoptosis B Kniep, E Kniep, N Özkucur, S Barz, M Bachmann, F Malisan, R Testi, ... International journal of cancer 119 (1), 67-73, 2006 | 70 | 2006 |
B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro [see comments] F Malisan, AC Fluckiger, S Ho, C Guret, J Banchereau, H Martinez-Valdez | 65 | 1996 |
Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis BM Simon, F Malisan, R Testi, P Nicotera, M Leist Cell Death & Differentiation 9 (7), 758-767, 2002 | 64 | 2002 |
Preventing the ubiquitin–proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia A Rufini, S Fortuni, G Arcuri, I Condo, D Serio, O Incani, F Malisan, ... Human molecular genetics 20 (7), 1253-1261, 2011 | 63 | 2011 |
Frataxin participates to the hypoxia-induced response in tumors I Guccini, D Serio, I Condo, A Rufini, B Tomassini, A Mangiola, G Maira, ... Cell death & disease 2 (2), e123-e123, 2011 | 60 | 2011 |
E3 ligase RNF126 directly ubiquitinates frataxin, promoting its degradation: identification of a potential therapeutic target for Friedreich ataxia M Benini, S Fortuni, I Condō, G Alfedi, F Malisan, N Toschi, D Serio, ... Cell reports 18 (8), 2007-2017, 2017 | 49 | 2017 |
Lipid signaling in CD95-mediated apoptosis F Malisan, R Testi FEBS letters 452 (1-2), 100-103, 1999 | 46 | 1999 |
Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs) L Leone, S Raffa, M Vetrano, D Ranieri, F Malisan, C Scrofani, ... Oncotarget 7 (6), 6410, 2016 | 42 | 2016 |